chartexchange

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2026

PR Newswire | Nov 5, 2026 4:10 PM EST

Net revenues of $207.6 million for the three months ended September 30, 2026 GAAP net income of $37.8 million, or $0.87 per share, for the third quarter Adjusted non-GAAP net income of $49.3 million, or $1.14 per share, for the third quarter Company to hold a conference call today at 2:00...

Read original article